Sialylation as a checkpoint for inflammatory and complement-related retinal diseases

Area of Science:

• Neuroscience
• Immunology
• Biochemistry

Background:

• Sialylation, the addition of sialic acid (Sia) to glycoproteins/glycolipids, regulates immune and complement systems in the retina.
• Reduced sialylation with aging in the CNS, including the retina, may drive chronic inflammation.
• Key retinal proteins like Complement factor H (FH) and SIGLEC receptors interact with sialic acid residues.

Purpose of the Study:

• To investigate the role of hyposialylation in age-related retinal inflammation and disease.
• To explore the therapeutic potential of polysialic acid (polySia) in mitigating retinal immune responses and damage.

Main Methods:

• Utilized genetically induced hyposialylation models in mice to study retinal inflammation.
• Administered intravitreal polysialic acid (polySia) to assess its effects on innate immune responses and vascular damage.
• Analyzed gene transcript pathways in hyposialylated mouse retinas.

Main Results:

• Genetically induced hyposialylation in mice caused age-related, complement C3-mediated retinal inflammation and bipolar cell loss.
• Hyposialylation-associated gene pathways in mice overlap with those in age-related macular degeneration (AMD).
• Intravitreal polySia application modulated innate immunity, inhibited complement activation, and protected against vascular damage in humanized SIGLEC-11 models.

Conclusions:

• Hyposialylation is a significant age-related factor in inflammatory retinal diseases like AMD.
• Sialic acid-based biologics, such as polySia, offer potential novel therapeutic strategies for complement-related retinal conditions.
• Restoring retinal sialylation may be a viable approach to prevent or treat age-related vision loss.